Cardiovascular Disease

Also known as: Heart Disease (colloquial) · CVD · Cardiovascular Disorders · Heart and Blood Vessel Disease

Definition

Cardiovascular Disease (CVD) is the umbrella term for a group of disorders of the heart and blood vessels, principally coronary (ischaemic) heart disease and its heart attacks, cerebrovascular disease and its strokes, hypertension, rheumatic and congenital heart disease, cardiomyopathies, and thromboembolic disease such as deep-vein thrombosis and pulmonary embolism. Most CVD shares a common mechanical substrate — atherosclerosis, the buildup of lipid plaque in artery walls — and a common set of modifiable drivers: tobacco use, unhealthy diet, physical inactivity, harmful alcohol use, and the intermediate conditions they produce, namely raised blood pressure, blood glucose, and blood lipids. The World Health Organization estimates that CVD killed 19.8 million people in 2022 — about 32 percent of all deaths worldwide — with 85 percent of those deaths caused by heart attack and stroke, and over three quarters occurring in low- and middle-income countries. (WHO, Wikipedia)

Cardiovascular disease is the leading cause of death in the Philippines. Philippine Statistics Authority registration data consistently place ischaemic heart diseases first among causes of death — 85,868 deaths, or 19.4 percent of the national total, in the provisional January-to-October 2024 count — with cerebrovascular diseases among the top three killers alongside neoplasms, and hypertension-related disease close behind. The World Health Organization estimates that 16.8 million Filipino adults live with hypertension, the single largest driver of the country’s heart attacks and strokes. This entry covers the disease entity itself; the companion concept of cardiovascular health — the prevention-oriented behaviors and markers that forestall these diseases — is treated in this wiki’s entry of that name. (PSA, WHO WPRO, PMC)

Identities

Source Type	Identity
Wikipedia	Cardiovascular disease
Wikidata	Q389735
DBpedia	Cardiovascular_disease
ProductOntology	N/A
Wiktionary	cardiovascular disease
Library of Congress Subject Headings (LCSH)	Cardiovascular system—Diseases
MeSH	Cardiovascular Diseases (D002318)
NCBI Taxonomy	N/A
AGROVOC	N/A
Google Scholar	cardiovascular disease Philippines ischaemic heart hypertension stroke mortality
ConceptNet	N/A
OpenCyc	N/A

Also Known As

Heart Disease (colloquial)
CVD
Cardiovascular Disorders
Heart and Blood Vessel Disease

Examples and Analogies

The supply line analogy: The coronary arteries are a city’s water mains feeding the pumping station itself. Atherosclerosis slowly narrows the pipes; a ruptured plaque is a sudden blockage — the heart muscle downstream starves within minutes, a heart attack. (Wikipedia)
The overpressure analogy: Hypertension is plumbing run at pressures the pipes were never rated for. Years of overload stiffen vessels, strain the pump, and either burst a pipe in the brain (haemorrhagic stroke) or help clot off a narrowed one (ischaemic stroke). (Wikipedia)
Concrete example — the statistics embodied: A 55-year-old Filipino male smoker with untreated hypertension and a salty, processed diet is the archetypal PSA mortality statistic; the same man with controlled blood pressure, no tobacco, and daily walking is the archetype of prevention described in the cardiovascular health entry. (PMC, PSA)
Concrete example — the silent precursor: A barangay health worker measures a vendor’s blood pressure at 150/95 mmHg at a market-day screening; she feels fine, yet this single uncontrolled number places her on the path tracked by millions of Filipinos toward stroke or heart failure. (WHO WPRO)

Usage Scenarios

1. Interpreting an Annual Check-Up

A 48-year-old manager in Makati has blood pressure of 140/90 mmHg and a borderline fasting glucose. His physician stages this as early cardiovascular disease risk: confirmatory pressure readings, lipid profile, lifestyle counseling, and antihypertensive therapy if targets are missed — the clinical sequence recommended in national and WHO guidance. (DOH, WHO)

2. Recognizing a Stroke in the Community

A barangay volunteer trained under Department of Health noncommunicable-disease programs recognizes sudden one-sided weakness and slurred speech in a neighbor and rushes him to the nearest emergency department. Rapid recognition matters because time-starved brain tissue determines outcome in cerebrovascular disease, the Philippines’ top-three killer. (DOH, PSA)

3. Enrolling in Hypertension Care at the Rural Health Unit

A farmer in Iloilo with persistent high readings joins a structured hypertension program of the kind supported by the WHO and Department of Health, in which community teams manage blood pressure with protocolized medicines and follow-up — an approach documented to bring most enrolled patients under control. (WHO WPRO)

4. Recovering After a Heart Attack

A post-myocardial-infarction patient at a Cebu tertiary hospital enters cardiac rehabilitation — supervised exercise, medication optimization, smoking cessation, and nutrition counseling — to prevent the second event that Philippine mortality data show is so often fatal. (PMC)

Strategies

Know your numbers early and often: blood pressure, fasting glucose, and lipids, since hypertension’s 16.8-million-strong Filipino prevalence makes screening the highest-yield first step. (WHO WPRO, DOH)
Control blood pressure faithfully once diagnosed, with daily medication rather than symptom-triggered dosing; uncontrolled hypertension powers most Philippine strokes and heart failures. (PMC)
Cut sodium from condiments, processed meats, and instant noodles — the dominant salt sources in Filipino diets — and build meals around vegetables, fruit, and lean protein. (PMC)
Stop tobacco in all forms, including vaping, and keep alcohol moderate; both raise cardiovascular risk at the population level. (WHO)
Accumulate at least 150 minutes of moderate activity weekly and pursue the prevention behaviors detailed in this wiki’s cardiovascular health entry rather than waiting for symptoms. (WHO)

Security and Safety Measures

Treat chest pressure radiating to arm or jaw, sudden one-sided weakness, or slurred speech as emergencies requiring immediate transport to hospital — not rest, massage, or home remedies, which cost Filipino stroke and infarct patients irrecoverable time. (WHO)
Never self-adjust or stop heart medicines; antihypertensives, anticoagulants, and statins require physician supervision, and abrupt cessation can trigger rebound crises or clotting. (WHO)
Buy medicines only from licensed pharmacies and verify registration through the FDA Philippines portal to avoid counterfeit cardiovascular drugs flagged in FDA advisories. (FDA Philippines)
Be wary of supplements or “cleanses” marketed as cures for heart disease, hypertension, or blocked arteries; they carry no approved therapeutic claims and may interact with prescribed drugs. (FDA Philippines)

Historical Context

Cardiovascular medicine’s modern era began with the Framingham Heart Study in 1948, which crystallized the “risk factor” concept — hypertension, smoking, cholesterol, diabetes — and converted heart disease from an act of fate into a calculable, modifiable risk. Later decades added effective antihypertensives, statins, thrombolysis, angioplasty, and bypass surgery, halving mortality in many high-income countries even as risk factors globalized. (Wikipedia, WHO)

The Philippines traced the classic epidemiological transition: as infectious-disease deaths declined, ischaemic heart disease and cerebrovascular disease climbed to the top of PSA mortality tables, where they remain. The Department of Health responded with universal hypertension and diabetes screening, PhilHealth outpatient packages, and WHO-supported programs that have enrolled thousands of adults in structured hypertension care — yet Philippine analysts document persistently late detection, low control rates, and out-of-pocket costs that blunt these tools, sustaining the country’s position among nations with the highest CVD burden in the Western Pacific region. (PSA, WHO WPRO, PMC)

Challenges and Controversies

A Leading Killer That Prevention Has Not Yet Tamed

Despite inexpensive, proven interventions, CVD remains the Philippines’ top cause of death year after year. Philippine health-services researchers point to system-level causes: hypertension detected only after organ damage, low medication adherence, fragmented follow-up across an archipelago, and specialist care concentrated in urban centers — with catastrophic costs for rural families. Household studies confirm that hypertension, diabetes, and heart disease dominate out-of-pocket NCD spending, deepening inequity in who survives. (PMC, PMC OOP)

Financing Gaps and the Politics of Health Spending

Cardiovascular outcomes have become entangled in the larger Philippine debate over health financing. The Universal Health Care Act of 2019 promised automatic enrollment and fuller coverage, but implementation analyses document chronic underfunding and pandemic-era disruption, while households continue to shoulder the largest single share of health spending. Commentators across the Duterte-era and post-2022 budgets have argued that public health was outpaced by other priorities, including the anti-drug campaign and later COVID response; whatever the accounting, researchers agree the result — households paying heavily for heart disease they could not afford to prevent — is the central unfinished business of Philippine CVD policy. (PMC UHC, PMC OOP)

Absolute-Risk Treatment and Who Qualifies

Guidelines increasingly favor treating cardiovascular risk as a whole rather than single thresholds, prompting debate over polypill population strategies versus targeted treatment in low- and middle-income settings, and over when younger Filipinos with modest risk should begin lifelong medication. (WHO)